🇺🇸 FDA
Patent

US 9511115

Pharmaceutical compositions for treating or preventing bone conditions

granted A61KA61K31/728A61K35/32

Quick answer

US patent 9511115 (Pharmaceutical compositions for treating or preventing bone conditions) held by The Regents of the University of California expires Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 01 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/728, A61K35/32, A61K38/1709, A61P